Biomolecular modification of implant surfaces

Expert Review of Medical Devices

Volumn 4, Issue 3, 2007, Pages 361-372

  Morra, Marco ^a  

^a Nobil Bio Ricerche Srl   (Italy)

Author keywords

Biomolecules; Collagen; Dental implants; Hyaluronan; Implant devices; Orthopedic implants; Peptides; Surface modifications; Vascular stents

Indexed keywords

ALBUMIN; BIOMATERIAL; COLLAGEN; FIBRIN; GLYCOSAMINOGLYCAN; GROWTH FACTOR; HEPARIN; HYALURONIC ACID; PEPTIDE; PHOSPHORYLCHOLINE; POLYMER; POLYTETREAFLUOROETHYLENE; PROTEIN P15; SCLEROPROTEIN; STEM CELL FACTOR RECEPTOR; TITANIUM; UNCLASSIFIED DRUG;

ANTICOAGULATION; ANTIINFLAMMATORY ACTIVITY; BIOCOMPATIBILITY; BIODEGRADATION; BIOENGINEERING; BIOLOGICAL ACTIVITY; BIOTECHNOLOGY; BLOOD CLOTTING DISORDER; BLOOD VESSEL PROSTHESIS; BONE DENSITY; BONE PROSTHESIS; BONE REGENERATION; CELL ADHESION; CELL TRANSPLANTATION; CORONARY STENT; DRUG ELUTING STENT; DRUG RELEASE; ENDOTHELIUM CELL; HUMAN; IMPLANT; LENS IMPLANT; MEDICAL INSTRUMENTATION; NONHUMAN; ORTHOPEDIC EQUIPMENT; OSSIFICATION; POSTOPERATIVE COMPLICATION; REVIEW; SURFACE PROPERTY; TOOTH IMPLANTATION; WOUND HEALING; WOUND HEALING IMPAIRMENT;

ANIMALS; BLOOD VESSEL PROSTHESIS; COATED MATERIALS, BIOCOMPATIBLE; DENTAL IMPLANTS; HUMANS; ORTHOPEDIC FIXATION DEVICES; RABBITS; STENTS; SURFACE PROPERTIES; TITANIUM;

EID: 34249818177     PISSN: 17434440     EISSN: 17452422     Source Type: Journal    
DOI: 10.1586/17434440.4.3.361     Document Type: Review

References (50)

1. Lagergren H, Olsson P, Swedenborg J. Inhibited platelet adhesion: a nonthrombogenic characteristic of a heparincoated surface. Surgay 75, 643-650 (1974).
2. Taguchi K, Takamura K, Nakagaki M, Morifuji K, Mochizuki T. Evaluation of thrombo-resistant surface after arterial implantation with special reference to hydron-coated surface treated with heparin. Hiroshima J. Med. Sci. 23, 41-49 (1974).
3. Idezuki Y, Watanabe H, Hagiwara M, Kanasugi K, Mori Y. Mechanism of antithrombogenicity of a new heparinized hydrophilic polymer: chronic in vivo studies and clinical application. Trans. Am. Soc. Artif. Intern. Organs 21, 436-439 (1975).
4. Larsson R. Biocompatible surfaces prepared by immobilized heparin or hyaluronate. Acta Otolaryngol 442 (Suppl.), 44-49 (1987).
5. Keates RH, Powell J, Blosser E. Coated intraocular lenses. Ophthalmic Surg. 18, 693-697 (1987).
6. Fagerholm P, Koul S, Trocme S. Corneal endothelial protection by heparin and sodium hyaluronate surface coating of PMMA intraocular lenses. Acta Ophthalmol. 182(Suppl.), 110-114 (1987).
7. Ksander GA, Gray L. Reduced capsule formation around soft silicone rubber prostheses coated with solid collagen. Ann. Plast. Surg. 14, 351-360 (1985).
8. Ksander GA. Collagen coatings reduce the incidence of capsule contracture around soft silicone rubber implants in animals. Ann. Plast. Surg. 20, 215-224 (1988).
9. Sideman S, Mor L, Brandes JM, Lupovitch S. Preparation of a biocompatible albumin-coated ion exchange resin for bilirubin removal from the blood of jaundiced newborns. J. Biomed. Mater. Res. 17, 91-107 (1983).
10. Hayward JA, Chapman D. Biomembrane surfaces as models for polymer design: the potential for haemocompatibility. Biomaterials 5, 135-142 (1984).
11. Bianchi JJ, Swartz MT, Raithel SC et al. Initial clinical experience with centrifugal pumps coated with the Carmeda process. ASAIO J. 38, M143-M146 (1992).
12. Stenach N, Korn RL, Fisher CA, Jeevanandam V, Addonizio VP. The effects of heparin bound surface modification (Carmeda Bioactive Surface) on human platelet alterations during simulated extracorporeal circulation. J. Extra Corpor. Technol. 24, 97-102 (1992).
13. Massia SP, Hubbell JA. Covalently attached GRGD on polymer surfaces promotes biospecific adhesion of mammalian cells. Ann. NY Acad. Sci. 589, 261-270 (1990).
14. Pierschbacher MD, Ruostahti E. Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule. Nature 309, 30-33 (1984).
15. Pierschbacher MD, Ruoslahti E. Variants of the cell recognition site of fibronectin that retain attachment-promoting activity. Proc. Natl. Acad. Sci. USA 81, 5985-5988 (1984).
16. Ratner B. The blood compatibility catastrophe. J. Biomed. Mater. Res. 27, 283-287 (1993).
17. Ratner B. New Ideas in biomaterials science - a path to engineered biomaterials. J. Biomed. Mater. Res. 27, 837-850 (1993).
18. Kasemo B. Biological surface science. Surface Sci. 500, 656-677 (2002).
19. Plant AL, Chen CS, Groves JT, Parikh AN. The biomolecular interface. Langmuir 19(5), 1449-1918 (2003).
20. Linder L, Albrektsson T, Branemark PI et al. Electron microscopic analysis of the bone-titanium interface. Acta Orthop. Scand. 54, 45-52 (1983).
21. Davies JE. The Bone-Biomaterial Interface. Toronto University Press, Toronto, Canada (1991).
22. Davies JE. Bone Engineering. Em squared, Toronto, Canada (2000).
23. Brunette DM, Tengvall P, Textor M, Thomsen P. Titanium in Medicine. Springer, Berlin, Germany (2001).
24. Ellingsen JE, Petter Lyngstadaas S. Bio-Implant Interface. CRC Press, FL, USA (2003).
25. Boyan BD, Lossdorfer S, Wang L. et al. Osteoblasts generate an asteogenic microenvironment when grown on surfaces with rough microtopographies. Eur. Cell Mater. 6, 22-27 (2003).
26. Park JY, Gemmell CH, Davies JE. Platelet interactions with titanium: modulation of platelet activity by surface topography. Biomaterials 22, 2671-2682 (2001).
27. Sul YT. The significance of the surface properties of oxidized titanium to the bone response: special emphasis on potential biochemical bonding of oxidized titanium implant. Biomaterials 24, 3893-3907 (2003).
28. Morra M. Biochemical modification of titanium surfaces: peptides and ECM proteins. Eur. Cell Mater. 12, 1-15 (2006).
29. Hammerie C. Current Issues forum. Int. J. Oral Maxillofac. Implants 20, 311-312 (2005).
30. Lebaron RG, Athanasiou KA. Extracellular matrix cell adhesion peptides: functional applications in orthopedic material. Tissue Eng. 6, 85-103 (2000).
31. Grzesik WJ, Robey PG. Bone matrix RGD glycoproteins: immunolocalization and interaction with human primary osteoblastic bone cells in vitro. J. Bone Min. Res. 9, 487-496 (1994).
32. Fairman R, Akerfeldt KS. Peptides as novel smart materials. Curr. Opin. Struct. Biol. 15, 453-463 (2005).
33. Dean JW 3rd, Culbertson KC, D'Angelo AM. Fibronectin and laminin enhance gingival cell attachment to dental implant surfaces in vitro. Int. J. Oral Maxillofac. Implants 10, 721-728 (1995).
34. El-Ghannam A, Starr L, Jones J. Laminin-5 coating enhances epithelial cell attachment, spreading, and hemidesmosome assembly on Ti-6A1-4V implant materials in vitro. J. Biomed. Mater. Res. 41, 30-40 (1998).
35. Tamura RN, Oda D, Quaranta V et al. Coating of titanium alloy with soluble laminin-5 promotes cell attachment and hemidesmosome assembly in gingival epithelial cells: potential application to dental implants. J. Periodotal. Res. 32, 287-294 (1997).
36. O'Toole GC, Salih E, Gallagher C. FitzPatrick D, O'Higgins N, O'Rourke SK. Bone sialoprotein-coated femoral implants are osteoinductive but mechanically compromised. J. Orthop. Res. 22, 641-646 (2004).
37. Jikko A, Harris SE, Chen D, Mendrick DL, Damsky CH. Collagen integrin receptors regulate early osteoblast differentiation induced by BMP-2. J. Bone Miner. Res. 14, 1075-1083 (1999).
38. Mizuno M, Fujisawa R, Kuboki Y. Type I collagen-induced osteoblastic differentiation of bone-marrow cells mediated by collagen-α2β1 integrin interaction. J. Cell Physiol. 184, 207-213 (2000).
39. Salasznyk RM, Williams WA, Boskey A, Batorsky A, Plopper GE. Adhesion to vitronectin and collagen I promotes osteogenic differentiation of human mesenchymal stem cells. J. Biomed. Biotechnol. 1, 24-34 (2004).
40. Ferris DM, Moodie GD, Dimond PM, Gioranni CW, Ehrlich MG, Valentini RF. RGD-coated titanium implants stimulate increased bone formation in vivo. Biomaterials 20, 2323-2331 (1999).
41. Kroese-DeutmanHC, Van Den Dolder J, Spauwen PHM, Jansen JA. Influence of RGD-loaded titanium implants on bone formation in vivo. Tissue Eng. 11, 1867-1875 (2005).
42. Elmengaard B, Bechtold JE, Soballe K. In vivo effects of RGD-coated titanium implants inserted in two bone-gap models. J. Biomed. Mater. Res. A 75, 249-255 (2005).
43. Elmengaard B, Bechtold JE, Soballe K. In vivo study of the effect of RGD treatment on bone ongrowth on press-fit titanium alloy implants. Biomaterials 26, 3521-3526 (2005).
44. Schliephake H, Scharnweber D, Dard M, Sewing A, Aref A, Roessler S. Functionalization of dental implant surfaces using adhesion molecules. J. Biomed. Mater. Res. B Appl. Biomater. 73B, 88-96 (2005).
45. Bernhardt R, van den Dolder J, Bierbaum S et al. Osteoconductive modifications of Ti-implants in a goat defect model: characterization of bone growth with SR μCT and histology. Biomaterials 26, 3009-3019 (2005).
46. Morra M, Cassinelli C, Cascardo G et al. Surface engineering of titanium by collagen immobilization. Surface characterization and in vitro and in vivo studies. Biomaterials 24, 4639-4654 (2003).
47. Rammelt S, Schulze E, Bernhardt R et al. Coating of titanium implants with type-I collagen. J. Orthop. Res. 22, 1025-1034 (2004).
48. Morra M, Cassinelli C, Meda L, Fini M, Giavaresi G, Giardino R. Surface analysis and effects on interfacial bone microhardness of collagen-coated titanium implants: a rabbit model. Int. J. Oral Maxillofac. Implants 20, 23-30 (2005).
49. Morra M, Cassinelli C, Cascardo G et al. Collagen I-coated porous titanium surfaces: mesenchymal cell adhesion and in vivo evaluation in trabecular bone implants. J. Biomed. Mater. Res. A 78, 449-458 (2006).
50. Svehla M, Morberg P, Bruce W, Walsh WR. No effect of a type I collagen gel coating in uncemented implant fixation. J. Biomed. Mater Res. B Appl. Biomater. 74, 423-428 (2005).